{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:01:50Z","timestamp":1761224510514,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.drudis.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T13:14:22Z","timestamp":1525698862000},"page":"1305-1311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases"],"prefix":"10.1016","volume":"23","author":[{"given":"Masaaki","family":"Waragai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuei","family":"Sugama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2018.05.009_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-016-0001-1","article-title":"Combined immunotherapy with \u2018anti-insulin resistance therapy\u2019 as a novel therapeutic strategy against neurodegenerative diseases","volume":"3","author":"Takamatasu","year":"2017","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.drudis.2018.05.009_bib0015","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged","volume":"66","author":"Craft","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0020","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson\u2019s disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2018.05.009_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdi.12420","article-title":"Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus","volume":"7","author":"Groeneveld","year":"2016","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.drudis.2018.05.009_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2013.01.001","article-title":"Adiponectin receptor as a key player in healthy longevity and obesity-related diseases","volume":"17","author":"Yamauchi","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.drudis.2018.05.009_bib0035","doi-asserted-by":"crossref","first-page":"40352","DOI":"10.1074\/jbc.M300365200","article-title":"Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin","volume":"278","author":"Waki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2018.05.009_bib0040","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/acn3.436","article-title":"Importance of adiponectin activity in the pathogenesis of Alzheimer\u2019s disease","volume":"4","author":"Waragai","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0045","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1038\/npjamd.2015.13","article-title":"Adiponectin\/adiponectin receptor in disease and aging","volume":"1","author":"Iwabu","year":"2015","journal-title":"NPJ Aging Mech. Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.beem.2013.08.006","article-title":"Adiponectin as a routine clinical biomarker","volume":"28","author":"Kishida","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2018.05.009_bib0055","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-151201","article-title":"Serum adiponectin levels, neuroimaging, and cognition in the Mayo Clinic Study of Aging","volume":"53","author":"Wennberg","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0060","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s12032-010-9617-x","article-title":"Adiponectin and breast cancer","volume":"28","author":"Chen","year":"2011","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0065","doi-asserted-by":"crossref","first-page":"975178","DOI":"10.1155\/2014\/975178","article-title":"Adiponectin as a biomarker of osteoporosis in postmenopausal women: controversies","volume":"2014","author":"Lubkowska","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.drudis.2018.05.009_bib0070","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fphys.2016.00439","article-title":"Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy","volume":"7","author":"Roy","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2014.08.002","article-title":"Adipokines as emerging depression biomarkers: a systematic review and meta-analysis","volume":"59","author":"Carvalho","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drudis.2018.05.009_bib0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jad.2017.06.015","article-title":"Decreased plasma adiponectin among male firefighters with symptoms of post-traumatic stress disorder","volume":"221","author":"Na","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.drudis.2018.05.009_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122664","article-title":"Association of CDH13 genotypes\/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect","volume":"10","author":"Teng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.05.009_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/COPD.S7739","article-title":"Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia","volume":"5","author":"Baldi","year":"2010","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1478-811X-7-27","article-title":"Leptin and adiponectin: new players in the field of tumor cell and leukocyte migration","volume":"7","author":"Lang","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.drudis.2018.05.009_bib0100","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2018.05.009_bib0105","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2265.2004.02182.x","article-title":"Ageing and plasma adiponectin concentration in apparently healthy males and females","volume":"62","author":"Adamczak","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bst0310457","article-title":"Centenarians as a model for healthy aging","volume":"31","author":"Franceschi","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.drudis.2018.05.009_bib0115","first-page":"51","article-title":"Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in African Americans","volume":"2","author":"Doumatey","year":"2012","journal-title":"J. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2018.05.009_bib0120","article-title":"Hyperadiponectinemia during infliximab induction therapy in pediatric Crohn\u2019s disease","author":"Frivolt","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.drudis.2018.05.009_bib0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneurol.2011.670","article-title":"Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study","volume":"69","author":"van Himbergen","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0130","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3233\/JAD-151116","article-title":"Possible involvement of adiponectin, the anti-diabetes molecule, in the pathogenesis of Alzheimer\u2019s disease","volume":"52","author":"Waragai","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/acn3.77","article-title":"Disease-modifying effect of adiponectin in model of alpha-synucleinopathies","volume":"1","author":"Sekiyama","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jcsm.12086","article-title":"Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure","volume":"7","author":"Sente","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.drudis.2018.05.009_bib0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.14310\/horm.2002.1698","article-title":"Adiponectin and end-stage renal disease","volume":"15","author":"Markaki","year":"2016","journal-title":"Hormones"},{"key":"10.1016\/j.drudis.2018.05.009_bib0150","first-page":"515","article-title":"Association of plasma adiponectin levels with cellular hydration state measured using bioelectrical impedance analysis in patients with COPD","volume":"7","author":"Yoshikawa","year":"2012","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0155","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaci.2007.10.018","article-title":"Adiponectin and inflammation: consensus and controversy","volume":"121","author":"Fantuzzi","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/eje.0.1480293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"Diez","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0165","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00535-013-0898-7","article-title":"Increased adiponectin associated with poor survival in hepatocellular carcinoma","volume":"49","author":"Wang","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0170","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","article-title":"Adiponectin and its receptors are expressed in bone-forming cells","volume":"35","author":"Berner","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.drudis.2018.05.009_bib0175","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00395-013-0390-9","article-title":"Secretion of adiponectin from mouse aorta and its role in cold storage?induced vascular dysfunction","volume":"108","author":"Ebner","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052354","article-title":"Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity","volume":"7","author":"Chan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.05.009_bib0185","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1038\/srep11708","article-title":"Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus","volume":"5","author":"Ali","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drudis.2018.05.009_bib0190","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1111\/bph.13619","article-title":"Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease","volume":"174","author":"Woodward","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tcm.2008.10.001","article-title":"Implications of myocardial matrix remodeling by adipokines in obesity-related heart failure","volume":"18","author":"Schram","year":"2008","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.drudis.2018.05.009_bib0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1568008033340090","article-title":"Dual roles of adiponectin\/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine","volume":"3","author":"Yamauchi","year":"2003","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"10.1016\/j.drudis.2018.05.009_bib0205","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.3892\/etm.2016.3872","article-title":"Different forms of adiponectin reduce the apoptotic and damaging effect of cigarette smoke extract on human bronchial epithelial cells","volume":"12","author":"Cheng","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.drudis.2018.05.009_bib0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/biof.83","article-title":"Effect of adiponectin on apoptosis: proapoptosis or antiapoptosis?","volume":"36","author":"Sun","year":"2010","journal-title":"Biofactors"},{"key":"10.1016\/j.drudis.2018.05.009_bib0215","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3233\/JAD-151015","article-title":"Insight into the dissociation of behavior from histology in synucleinopathies and in related neurodegenerative diseases","volume":"52","author":"Sekiyama","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005631","article-title":"Grandmothering and cognitive resources are required for the emergence of menopause and extensive post-reproductive lifespan","volume":"13","author":"Aime","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0225","first-page":"433","article-title":"Risk factor paradox in wasting diseases","volume":"10","author":"Kalantar-Zadeh","year":"2007","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.drudis.2018.05.009_bib0230","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pcad.2013.10.005","article-title":"Obesity paradox in end-stage kidney disease patients","volume":"56","author":"Park","year":"2014","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.drudis.2018.05.009_bib0235","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","article-title":"BMI and risk of dementia in two million people over two decades: a retrospective cohort study","volume":"3","author":"Qizilbash","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168247","article-title":"Body mass index-related mortality in patients with type 2 diabetes and heterogeneity in obesity paradox studies: a dose-response meta-analysis","volume":"12","author":"Kwon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2018.05.009_bib0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/HYPERTENSIONAHA.117.09790","article-title":"Obesity paradox in hypertension: is this because sympathetic activation in obesity-hypertension takes a benign form?","volume":"71","author":"Esler","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.drudis.2018.05.009_bib0250","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","article-title":"Obesity and cardiovascular disease","volume":"118","author":"Ortega","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2018.05.009_bib0255","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.05.009_bib0260","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1468-1331.2010.03194.x","article-title":"Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer\u2019s disease","volume":"18","author":"Une","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0265","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/14786419.2014.971317","article-title":"Molecular docking study on platelet-activating factor antagonistic activity of bioactive compounds isolated from Guttiferae and Ardisia species","volume":"29","author":"Jasamai","year":"2015","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.drudis.2018.05.009_bib0270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.taap.2013.03.030","article-title":"Inverse antagonist activities of parabens on human oestrogen-related receptor gamma (ERRgamma): in vitro and in silico studies","volume":"270","author":"Zhang","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0275","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22020340","article-title":"Recent advances and applications of molecular docking to G protein\u2013coupled receptors","volume":"22","author":"Bartuzi","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2018.05.009_bib0280","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2018.05.009_bib0285","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.drudis.2018.05.009_bib0290","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-3-319-48382-5_25","article-title":"Obesity-associated breast cancer: analysis of risk factors","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0295","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2011.01560.x","article-title":"Adiponectin receptor signalling in the brain","volume":"165","author":"Thundyil","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.05.009_bib0300","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMp1701047","article-title":"The failure of solanezumab \u2013 how the FDA saved taxpayers billions","volume":"376","author":"Sacks","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drudis.2018.05.009_bib0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(16)30395-7","article-title":"Solanezumab: too late in mild Alzheimer\u2019s disease?","volume":"16","author":"Anon","year":"2017","journal-title":"Lancet Neurol."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618300813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644618300813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:34:59Z","timestamp":1761222899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644618300813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1359644618300813"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.05.009","relation":{},"ISSN":["1359-6446"],"issn-type":[{"type":"print","value":"1359-6446"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}